Bio-Techne Corporation
TECH
$72.25
-$0.06-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 3.14% | 5.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.14% | 5.25% | |||
| Cost of Revenue | 7.02% | -0.69% | |||
| Gross Profit | 1.25% | 8.41% | |||
| SG&A Expenses | -8.32% | -3.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.56% | -1.98% | |||
| Operating Income | 14.12% | 34.79% | |||
| Income Before Tax | -0.77% | 40.25% | |||
| Income Tax Expenses | -20.41% | 57.95% | |||
| Earnings from Continuing Operations | 7.00% | 34.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.00% | 34.30% | |||
| EBIT | 14.12% | 34.79% | |||
| EBITDA | 10.76% | 23.77% | |||
| EPS Basic | 7.23% | 33.87% | |||
| Normalized Basic EPS | 23.90% | 35.62% | |||
| EPS Diluted | 9.41% | 33.33% | |||
| Normalized Diluted EPS | 24.04% | 35.71% | |||
| Average Basic Shares Outstanding | -0.15% | 0.31% | |||
| Average Diluted Shares Outstanding | -0.24% | 0.26% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.07% | -0.25% | |||